A recombinant murine retrovirus vector containing the v-erbB gene of avian erthroblastosis virus was constructed to investigate v-erbB as a transforming gene for mammalian cells. A restriction fragment containing the v-erbB sequences from a molecular clone of avian erythroblastosis virus was inserted into a Moloney murine leukemia virus vector. The construct, designated MuLVIerbB, transformed NIH 3T3 cells at a high efficiency in the DNA transfection assay. Individual MuLVIerbB transfectants grew in soft agar and were tumorigenic. The transfectants contained v-erbB DNA sequences, expressed v-erbB-specific transcripts, and synthesized v-erbB-related glycoproteins. The majority of transfectants produced two major v-erbB gene products of 58 and 66 kilodaltons. However, some transfectants produced much smaller v-erbB-specific proteins. Tunicamycin experiments revealed that the size heterogeneity observed between different transfectants was not due to variations in glycoprotein processing, implying that, in some cases, alterations in the MuLVIerbB genome occurred during the transfection process. These findings indicate that expression of the complete v-erbB gene product is not required for transformation of NIH 3T3 cells. A transmissible murine v-erbB (M-erbB) virus was generated by infection of nonproducer transfectants with amphotrophic murine leukemia virus. Transmission of the rescued M-erbB virus was confirmed by DNA, RNA, and protein analyses.
Avian erythroblastosis virus (AEV) is a replicationdefective retrovirus which induces erythroblastosis, sarcomas, and carcinomas in chickens (16, 19, 20) and transforms immature erythroid cells and fibroblasts in vitro (for a review, see reference 19) . The genome of AEV contains two oncogenes, v-erbA and v-erbB, which code for a hybrid protein, p75gag-erbA, and for an integral membrane glycoprotein, gp74erbB, respectively (9, 23, 30, 34, 35) . Studies with deletion mutants in v-erbA or v-erbB have indicated that v-erbB is the principal transformning gene of AEV (17, 40) . Moreover, a new virus isolate, AEV-H, which contains only the v-erbB gene, retains the capacity to transform avian fibroblasts and induces weak erythroblast transformation in vitro (27, 49) . Although v-erbB alone is sufficient to induce fibroblast transformation, v-erbA is thought to cooperate with v-erbB to enhance transformation and block differentiation of avian erythroblasts (27) .
The gene products of the src family of retroviral oncogenes and the receptors for several growth factors exhibit tyrosine-specific kinase activity (for a review, see reference 25) . The v-erbB gene is a member of the src gene family, and its protein product shares amino acid homology with other members of this group, particularly within the domain responsible for tyrosine-specific protein kinase activity (36, 50) . Recently, it has been found that the predicted v-erbB gene sequence possesses extensive homology with that of the human epidermal growth factor (EGF) receptor (14) . The v-erbB glycoprotein represents a truncated form of the mammalian EGF receptor which has retained transmembrane and cytoplasmic domains but lacks the EGF-binding domain. The v-erbB gene product is also slightly truncated at * Corresponding author. its cytoplasmic terminus but still retains the tyrosine kinase activity in this region of the molecule (18, 29) .
Analysis of the range of mammalian target cells susceptible to transformation by v-erbB has been impaired by difficulties in introducing this avian virus into mammalian cells. Transformation of mammalian cells with AEV, by virus infection or by transfection, occurs only at very low frequencies (11, 37) . In addition, transformation of mammalian fibroblasts by these approaches does not lead to productive infection or the ability to rescue infectious virus containing v-erbB. With the advent of recombinant DNA technology, it has become possible to construct mammalian retroviruses containing a variety of foreign genes. In the present report, we describe the constructioti and characterization of a v-erbB-containing murine retrovirus which allows for more extensive investigation of the function of this EGF receptor-related gene as a transforming or growthpromoting gene in well-defined mammalian systems.
MATERIALS AND METHODS
Cells and viruses. Continuous mouse NIH 3T3 (26) , normal rat kidney (15) , mink epithelial MvlLu (CCL64) (24) , and 501 normal human fibroblast (3) cell lines have been described. Clonal simian sarcoma virus-transformed nonproducer normal rat kidney cell line (2) and Snyder-McDonough feline sarcoma virus-transformed nonproducer lines (7) were used. Murine leukemia virus (MuLV) pseudotypes of replicationdefective viruses were obtained by superinfection of appropriate nonproducer cells with a clonal strain of the mouse type C helper virus, amphotropic MuLV (22, 38 (46) . Construction of the MuLV/erbB vector was performed as described in Fig. 1 (32) . Transcripts were analyzed by hybridization with 32p_ labeled nick-translated v-erbB DNA (39) under the conditions described by Wahl et al. (47) .
Biosynthetic labeling and immunoprecipitation. The procedures for metabolic labeling and immunoprecipitation were as previously described (6 
RESULTS
Construction and characterization of a murine retrovirus vector containing the v-erbB gene. Our strategy for construction of a murine retrovirus vector containing v-erbB is summarized in Fig. 1 . The MuLV vector was derived from a Mo-MuLV provirus subcloned in pBR322 (5) by the procedure shown in Fig. 1A . We deleted major portions encompassing gag, pol, and env gene sequences from the vector but retained the two Mo-MuLV long terminal repeats (LTRs) needed for initiation and-polyadenylation of viral transcripts (28, 44) . The deleted Mo-MuLV vector also retained the region containing packaging sequences, the tRNA-binding site needed for efficient encapsidation of the viral genome, and sequences involved in the synthesis of plus-strand DNA (33) .
The method used to obtain a colinear v-erbB gene fragment for insertion into the MuLV vector is shown in Fig. 1B . The v-erbB gene used for insertion into the Mo-MuLV vector was present in a 3.5-kbp PstI fragment derived from a permuted molecular clone of AEV (46) . Our strategy in making the construct was to attempt to express the v-erbB gene product by using the ATG codon present at the beginning of its open reading frame. This was facilitated by the fact that the PstI fragment containing the insert has no open reading frame upstream of the ATG codon located 6 codons into the v-erbB open reading frame (13) . In addition, the gag gene sequence of the MuLV vector used was deleted of a small PstI-PstI fragment which contained the putative AUG for its initiation.
To establish whether the DNA construct, designated MuLV/erbB, was biologically active, we transfected NIH 3T3 cells with serial dilutions of the recombinant plasmid DNA. MuLVIerbB DNA had a transforming efficiency of 4 x 103 to 15 x 103 foci per ,ug of DNA insert (Table 1) . Cells within the MuLV/erbB-transformed foci exhibited a dense, fusiform morphology ( to possess known properties of malignant cells, including the ability to grow in soft agar and to form tumors in vivo (Table  1) .
To confirm that the v-erbB gene was responsible for induction of the transformed phenotype, DNAs from individual transfectants were analyzed for the presence of verbB sequences by Southern To further analyze the molecular structure of the integrated MuLV/erbB DNA, transfectant DNAs were restricted with XbaI, which uniquely cleaves the MuLV/erbB construct within the Mo-MuLV LTRs (Fig. 3C) products of 58 and 66 kDa (Fig. 4, lane 1A) . Several The size heterogeneity of v-erbB products observed among the different transfectants analyzed might be accounted for by differences in glycoprotein processing or could result from alterations which may have occurred in the genomic structure of the MuLV/erbB construct during the transfection process. To determine whether differences in glycosylation of the v-erbB gene products were the cause of the size variations, transfectants were exposed to tunicamycin, a specific inhibitor of glycosylation (43, 45) , during the radiolabeling period. Tunicamycin treatment altered the mobility of v-erbB-related proteins in all of the transfectants analyzed (Fig. 4) -related proteins To examine the structure of the rescued virus genome, I serum (Fig. 4) XbaI and hybridized with the 0.55-kbp v-erbB-specific BamHI fragment (Fig. 5, lanes 2 through 4) . Two major v-erbB-specific XbaI fragments of 4.2 and 5.4 kbp were detected in all three samples. Smaller fragments were also observed in one culture at a lower intensity (Fig. 5, lane 2) . Thus, all three virus-infected lines exhibited MuLV/erbB genomic deletions when compared to the original construct or the 422.14.1 transfectant, where XbaI cleavage generated 8-kbp v-erbB-specific genomic fragments (Fig. 3B, lane 2) . By double digestion with XbaI and EcoRI, which cleaves the original construct uniquely at the 3' end of v-erbB (Fig. 3C), we showed that the proviral deletions in each case affected the 3' end of the v-erbB coding region (Fig. 5, lanes (Fig. 6A? lane 3) . Restriction analysis with different enzymes revealed the preservation of the 5' PstI site, indicating the absence of any detectable deletion at the 5' terminus of the v-erbB coding sequence. However, a major deletion beginning distal to the second BamHI site in the v-erbB open reading frame and encompassing essentially the entire 3' region of the viral construct up to the 3' MuLV LTR (Fig.  6A, lanes 6, 9, and 12 ) was detected by restriction analysis. This deletion not only removed avian LTRs from the original construct but also may have deleted as many as 500 nucleotides of v-erbB coding sequence from its 3' terminus (Fig.  6B) .
We also compared v-erbB-containing RNA transcripts present in the parental 422.14.1 transfectant with those present in one of the mass cultures of M-erbB virus-infected NIH 3T3 cells. The transfectant contained two major verbB-containing mRNA species of around 4.3 and 3.3 kilobases (kb), as well as some minor high-molecular-weight species (Fig. 7, lane 1) . The sizes of the high-molecularweight species were consistent with a complete transcript of the 8.0-kbp genomic MuLVIerbB DNA construct, while the smaller species were consistent with unspliced or spliced subgenomic transcripts (or both) that prematurely terminated at the internal AEV LTR polyadenylation site (Fig.  3C ). Although precise comparisons between sizes of RNAs are difficult with gel analysis, the two major v-erbB RNAs in the M-erbB virus-infected cells were consistent with genomic transcripts of the two genomic M-erbB viral DNAs shown to be present in the same cells (Fig. 5, lane 2) . It should be noted that neither of these transcripts corresponded to any of the v-erbB RNA species in the parental 422.14.1 transfectant. We conclude from all of these results that the internal avian LTR sequences in the original construct led to inefficient virus rescuability due to premature termination of the genomic transcript and that efficiently rescuable M-erbB virus was associated with viral genomic deletions.
M-erbB virus-infected NIH 3T3 cells were next analyzed for the expression of v-erbB-specific products by immunoprecipitation with anti-v-erbB serum. Two separately infected mass cultures were each shown to produce two v-erbB-specific protein products of 58 and 66 kDa ( lanes 1A and 3A). The molecular sizes of these proteins shifted to 48, 62 , and 64 kDa after tunicamycin treatment (Fig. 8, lanes 2A and 4A) . The sizes of v-erbB-related translational products synthesized by M-erbB virus-infected NIH 3T3 cells closely resembled those observed in AEVtransformed avian erythroblasts (Fig. 8, lanes SA and 6A) and the parental 422.14.1 transfectant (Fig. 4, lanes 1A and  2A) . The cells infected with the smallest provirus, M-erbB clone 1, demonstrated a 56-kb v-erbB product, which migrated as a 48-kDa protein in tunicamycin-treated cells (data not shown). Thus, genomic deletions mapped to distal verbB coding sequences, in most cases, did not significantly alter the sizes of v-erbB products expressed by M-erbB virus-infected cells, although we identified one virus whose v-erbB transforming product was significantly decreased in size.
M-erbB virus transforming activity for different cell types. The mass population of M-erbB virus was able to induce foci on two continuous rodent fibroblast cell lines, NIH 3T3 and normal rat kidney, as well as on diploid, noncontinuous human fibroblasts (Table 2 ). In addition, this virus induced foci on the MvlLu mink cell line, which is of epithelial origin.
The M-erbB clone 1 with the same amphotropic helper virus ( Table 2 ). The oncogene of Snyder-McDonough feline sarcoma virus like v-erbB, has been reported to possess homology with a growth factor receptor. The normal counterpart of v-fms is thought to be the macrophage colony-stimulating factor (CFS-1) receptor (41) . In contrast, simian sarcoma virus whose sis oncogene encodes a PDGF-2-like growth factor polypeptide (31), effectively transformed each of the fibroblast-derived cell lines but induced no detectable alterations of MvlLu epithelial cells. These findings support the concept that the range of target cells whose growth can be altered by oncogenes encoding growth factors is limited to those possessing receptors for such factors (31) . While fibroblasts and epithelial cells analyzed possess EGF receptors, v-erbB can alter the growth of avian erythroblasts, which presumably lack this receptor (16, 19, 20) . Similarly, v-fms transformed fibroblasts and epithelial cells, which do not appear to express detectable levels of the CSF-1 receptor (41) . Thus, oncogene products derived from growth factor receptors appear to have a much wider range of target cells.
DISCUSSION
In the present studies, we describe the construction of a murine retrovirus which contains the v-erbB gene of AEV. By deletion of sequences required for replication by the replication-competent Mo-MuLV provirus and by insertion of a restriction fragment containing a linearized v-erbB gene, we generated an efficiently transforming DNA. Characterization of transfectants induced by the MuLV/erbB construct revealed the presence of v-erbB-specific DNA from the construct, as well as the expression of v-erbB-specific mRNAs and proteins. The v-erbB-specific proteins were glycosylated in mammalian cells, as is known to be the case for avian cells infected with AEV (23, 36) . We did observe variant MuLV/erbB DNA transfectants whose v-erbBrelated proteins were significantly smaller in both their glycosylated and nonglycosylated forms than those synthesized by the wild-type AEV genome. While we have not precisely mapped the deletions, these findings imply that Several lines of evidence argue that selection for efficiently rescued M-erbB virus required deletion of internal avian LTR sequences present in the original construct. Infectious M-erbB viruses preserved the v-erbB coding sequences required for transformation and expressed verbB-specific protein products whose molecular sizes closely resembled those of proteins encoded by AEV. Thus, the 2.0-and 3.0-kbp deletions in the two major viral genomic species generated must map to the 3' half of the original MuLV/erbB construct which contained the avian LTR sequences. In one clonal virus, we directly mapped the 3' deletion of v-erbB to encompass sequences distal to the second BamHI site in the v-erbB open reading frame as well as the entire avian LTR sequence and contiguous MuLV sequences up to the 3' LTR.
It has been reported that polyadenylation signals introduced within a retroviral DNA construct may lead to premature termination of a complete viral transcript and dramatically impair its rescuability as an infectious virus (44) .
Since avian LTRs contain such polyadenylation signals, it is likely that the presente of internal LTRs led to a MuLVIerbB RNA transcript containing the U5 portion of the Mo-MuLV LTR and ternIinating with the U3 portion of the avian LTR.
The observed major 4.3-and 3.3-kb v-erbB-related mRNA species in the parental MuLV/erbB DNA transfectants are consistent with such subgenomic transcripts. Reverse transcription of these subgenomic transcripts conceivably could generate a provirus with hybrid LTRs containing avian U3 and Mo-MuLV U5 sequences. However, the v-erbB transcripts detected in M-erbB virus-infected cultures had different sizes from those detected in the parental transfectant. These findings imply that the major 4. The sis transforming gene encodes a PDGF-like growth factor with a stringent specificity for target cells which possess PDGF receptors and, therefore, does not transform epithelial cells (31) . The generation of v-erbB-containing retroviruses capable of infecting a wide variety of mammalian target cells should be useful in characterizing the mechanisms by which a gene coding for the activated form of a growth factor receptor may alter the growth and differentiation of such cells. This will be of particular interest with respect to cell types that normally lack EGF receptors. If cell types not responsive to this activated oncogene can be detected, it is possible that such cells may be deficient in pathways of growth factor-mediated proliferation distal to receptor activation.
